Recent Updates
Recently added Catalysts
ICAD

iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th

Key Takeaway: NASHUA, N.H., Nov. 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine months ended September

Full Press Release Details

NASHUA, N.H., Nov. 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine months ended September 30, 2018 after the close of the market and host a conference call at 4:30pm Eastern Time on Tuesday, November 13th.
Tuesday, November 13 th @ 4:30pm Eastern Time
Domestic: 888-599-8686
International: 323-994-2093
Conference ID: 1529049
Webcast: http://public.viavid.com/index.php?id=131972
Replays available through November 27 th :
Domestic: 844-512-2921
International: 412-317-6671
Replay PIN: 1529049
In addition, a replay of the call will remain on the Company’s website (www.icadmed.com) until the Company releases its fourth quarter and year ended 2018 financial results.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
ARPR, on behalf of iCAD, Inc.
Last updated: Nov 6, 2018